# X4 Pharmaceuticals, Inc. (XFOR)

> 医疗保健 · US · 以 USD 报告

Sponda 的基本面指标，已按通胀调整。

[HTML 版本](https://sponda.capital/zh/XFOR/fundamentals)

## 年度数据

| 年份 | 营业收入 (M) | 净利润 (M) | FCF (M) | 债务 (M) | 股东权益 (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 11.51M | $ -36.40M | $ -40.39M | $ 77.22M | $ 155.45M |
| 2025 | $ 35.95M | $ -81.09M | $ -90.74M | $ 77.29M | $ 186.29M |
| 2024 | $ 2.69M | $ -39.36M | $ -137.93M | $ 78.09M | $ 22.15M |
| 2023 | $ 0 | $ -109.39M | $ -104.42M | $ 58.28M | $ 51.10M |
| 2022 | $ 0 | $ -104.86M | $ -86.25M | $ 38.42M | $ 74.05M |
| 2021 | $ 0 | $ -105.43M | $ -85.01M | $ 39.79M | $ 64.41M |
| 2020 | $ 3.82M | $ -79.15M | $ -76.67M | $ 38.45M | $ 72.80M |
| 2019 | $ 0 | $ -68.16M | $ -28.62M | $ 22.91M | $ 129.22M |
| 2018 | $ 0 | $ -43.96M | $ -51.69M | $ 9.83M | $ -11.68M |
| 2017 | $ 0 | $ -45.64M | $ -37.60M | $ 12.24M | $ 58.71M |
| 2016 | $ 0 | $ -4.82M | N/A | N/A | N/A |

此视图中不可用的列：annualPriceMultiples, dividends。它们需要实时市场数据，仅在 HTML 页面上显示。

## 杠杆与流动性

| 指标 | 数值 |
| --- | --- |
| 总债务 / 股东权益 | 0.50 |
| 总负债 / 股东权益 | 0.63 |
| 流动比率 | 11.30 |

## 其他视图

- [指标](https://sponda.capital/zh/XFOR.md)
- [图表](https://sponda.capital/zh/XFOR/charts.md)
- [对比](https://sponda.capital/zh/XFOR/compare.md)
- [指标定义](https://sponda.capital/zh/screener.md)

数据截至 2026-08-29。